Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFMW) Return on Assets (2016 - 2025)

Historic Return on Assets for Sunshine Biopharma (SBFMW) over the last 12 years, with Q3 2025 value amounting to 0.19%.

  • Sunshine Biopharma's Return on Assets fell 500.0% to 0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.18% for FY2024, which is 200.0% down from last year.
  • Per Sunshine Biopharma's latest filing, its Return on Assets stood at 0.19% for Q3 2025, which was down 500.0% from 0.21% recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Return on Assets ranged from a high of 0.06% in Q3 2022 and a low of 6.07% during Q3 2021
  • In the last 5 years, Sunshine Biopharma's Return on Assets had a median value of 0.21% in 2025 and averaged 1.41%.
  • As far as peak fluctuations go, Sunshine Biopharma's Return on Assets surged by 60100bps in 2022, and later plummeted by -8900bps in 2023.
  • Quarter analysis of 5 years shows Sunshine Biopharma's Return on Assets stood at 5.29% in 2021, then skyrocketed by 86bps to 0.76% in 2022, then skyrocketed by 79bps to 0.16% in 2023, then decreased by -3bps to 0.17% in 2024, then dropped by -12bps to 0.19% in 2025.
  • Its last three reported values are 0.19% in Q3 2025, 0.21% for Q2 2025, and 0.17% during Q1 2025.